The global bone regeneration market is poised for significant growth over the next decade, with an expected valuation of USD 5,380.75 million in 2023. According to market forecasts, the market is projected to expand at a compound annual growth rate (CAGR) of 3.8%, reaching an estimated USD 7,827.8 million by 2033.
Bone regeneration is a critical field within orthopedics and dentistry, involving the repair and regrowth of bone tissue. It encompasses a range of products and techniques designed to promote bone healing and regeneration, addressing conditions such as fractures, bone defects, and degenerative bone diseases.
Bone-regenerating therapy has become necessary due to the rising global incidence of bone disorders and the requirement for reconstructive surgery. Based on statistical data, around 10% of men and 18% of women over 60 have symptomatic osteoarthritis. Furthermore, there has been a discernible surge in hip fractures and bone injuries, particularly among athletes, which has raised the need for bone regeneration therapies.
Request Your Detailed Report Sample With Your Work Email:
https://www.futuremarketinsights.com/reports/sample/rep-gb-15486
In lieu of bone grafts, alternative methods are employed to treat delayed fracture unions, fuse the spine, correct irregularities in the bone, and fill cavities caused by a range of circumstances. The material comes from several sources such as demineralized bone matrix, autografts, allografts, synthetics, bone void fillers, and bone morphogenetic proteins.
Key Takeaways:
- The global bone regeneration market is expected to reach USD 7,827.8 million by 2033, reflecting a rise from USD 5,380.75 million in 2023.
- This growth is projected at a consistent compound annual growth rate (CAGR) of 3.8% throughout the forecast period.
- The increasing need for reconstructive surgeries and the growing prevalence of bone diseases are key drivers for market expansion.
Competitive Landscape:
Key competitors in the bone regeneration sector are focusing on collaborations, product launches, and expansion to achieve a dominant position in the market. With the use of these strategies, market participants can increase the number of products they offer and their market penetration. As a result, they have seen a rise in their overall revenue share in the global market for bone regeneration.
Given below are a few examples of the key strategies followed by the manufacturers:
- In March 2022, Biocomposites, a multinational maker of medical products, and Zimmer Biomet agreed to a multiyear distribution agreement for Genex Bone Graft Substitute in the orthopedic market in the USA This product features a new mixing mechanism and delivery options.
- In February 2020, Integra LifeSciences launched the AmnioExcel® Plus placental allograft membrane.
Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-15486
Key Players
- Medtronic plc.
- Stryker Corporation
- DePuy Synthes Inc.
- Integra Lifesciences Holdings Corporation
- Zimmer Biomet HoldingsInc.
- Xtant Medical HoldingsInc.
- Arthrex Inc.
- Baxter International Inc.
- Musculoskeletal Transplant Foundation
- Smith & NephewInc.
- Orthofix HoldingsInc.
- NuvasiveInc.
- Allosaurus
- NovaBone ProductsLLC
- BonAlive Biomaterials Ltd.
- Sigma Graft Biomaterials
- RTI Surgical
- Institut Straumann AG
- ExactechInc
- A.B. Dental Devices Ltd
- Geistlich Pharma AG
- BMT Group
- Osstem Implant
Key Segments:
By Product:
- Bone Grafts Substitutes
- Allografts
- Demineralized Bone Matrix(DBM)
- Others
- Xenograft
- Autografts
- Synthetic Bone Graft
- Bone Morphogenetic Protein(BMP)
- Allografts
- Bone Growth Stimulators
- Non-Invasive Electrical Bone Growth Stimulators
- Invasive Electrical Bone Growth Stimulators
By Application:
- Osteoarthritis (OA)
- Osteoporosis
- Rheumatoid Arthritis (RA)
- Spinal Disorders
- Dentistry
- Craniomaxillofacial (CMF)
- Trauma Cases
By Age Group:
- Pediatric
- Adults
- Geriatric
By End User:
- Hospitals
- Orthopedic Clinics
- Ambulatory Surgical Centers
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- The Middle East and Africa (MEA)
In-Depth Market Analysis: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/15486
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube